Biosimilars in Retina: Clinical Pearls

Susan Bressler, MD; and Timothy G. Murray, MD, MBA

Show Description +

Dr. Bressler provides a primer on what biosimilars are and how they might change clinical practice.

Posted: 3/24/2023

Keywords:

biosimilars

•

retina-meeting-recap

Up Next

Name: Biosimilars in Retina: Clinical Pearls
Uploaded: 2023-03-24T22:06:53+00:00
Description: Dr. Bressler provides a primer on what biosimilars are and how they might change clinical practice.

The Latest on Uveitis Management

Steven Yeh, MD; and Timothy G. Murray, MD, MBA

GA Therapy In Practice

Charles C. Wykoff, MD, PhD; and Timothy G. Murray, MD, MBA

Managing AMD Subtypes

Gregg T. Kokame, MD, MMM; and Timothy G. Murray, MD, MBA

Retinal Surgery Beyond the OR

Tarek S. Hassan, MD; and Timothy G. Murray, MD, MBA

Subretinal Fluid in Retinal Detachment: Stay or Go?

Stratos V. Gotzaridis, MD; Timothy G. Murray, MD, MBA

Consider Vitrectomy for DME

Zofia A. Nawrocka, MD, PhD; Timothy G. Murray, MD, MBA

Delivering Gene and Cell Therapies

Allen C. Ho, MD; and Timothy G. Murray, MD, MBA

Back to All Videos

Biosimilars in Retina: Clinical Pearls

Susan Bressler, MD; and Timothy G. Murray, MD, MBA

Dr. Bressler provides a primer on what biosimilars are and how they might change clinical practice.

Posted: 3/24/2023

Keywords:

biosimilars

•

retina-meeting-recap

Please log in to leave a comment.

More From ARDS: 2023 Coverage

Retinal Surgery Beyond the OR

Tarek S. Hassan, MD; and Timothy G. Murray, MD, MBA

Subretinal Fluid in Retinal Detachment: Stay or Go?

Stratos V. Gotzaridis, MD; Timothy G. Murray, MD, MBA

Consider Vitrectomy for DME

Zofia A. Nawrocka, MD, PhD; Timothy G. Murray, MD, MBA

Delivering Gene and Cell Therapies

Allen C. Ho, MD; and Timothy G. Murray, MD, MBA

Meeting Coverage:

Aspen Retinal Detachment Society

Biosimilars in Retina: Clinical Pearls

Up Next

Biosimilars in Retina: Clinical Pearls

More From ARDS: 2023 Coverage